Financial Services

With the market set to double by 2030, the IAAPI Expo 2026 showcases a sector grappling with rapid growth, new tech, and the critical issue of safety.

As Thames Water faces collapse, a new investigative podcast brings together key experts to dissect the systemic failures behind England's polluted rivers.

As Sweden nears smoke-free status with nicotine pouches, Argentina's ban on alternatives leaves millions of women at risk. A new report ignites the debate.

Recycling giant ATRenew appoints a JD.com investment director to its board, signaling a major move to dominate China's booming circular economy.

As UK youth reading hits a 20-year low, a new campaign empowers kids to write with purpose and choose books for their communities.

In a key move for India's energy security, InSolare partners with a top national lab to ensure renewable projects can withstand the test of time and climate.

At CONEXPO 2026, LiuGong unveils a bold two-front strategy, pushing advanced electric machines while reinforcing its heavy-duty diesel lineup for America.

After a major clinical trial failure, COSCIENS is shutting down its German pharma unit to focus on its profitable plant-based active ingredients business.

Nuveen is merging its BXMX and DIAX funds into SPXX, creating a larger, streamlined covered call CEF. What does this mean for investors and strategy?

With a newly expanded credit facility and a key banking partner, SUNS is doubling down on the booming commercial real estate markets of the Southern U.S.

OFS Credit's net asset value dropped 20% from market volatility, forcing a dividend cut. Can its strategic moves stabilize the ship for investors?

aTyr Pharma heads to a crucial FDA meeting for its lung drug efzofitimod, which missed its main goal but showed significant patient quality-of-life gains.

Outraged by Canada's enduring water crisis, Quebec high school students are taking their fight for Indigenous rights to the nation's capital.

NextCure accelerates its high-stakes ovarian cancer drug trial, but with cash dwindling, can it reach the finish line before time runs out?

The smart baby monitor firm posts a record $105.7M in 2025 revenue and positive adjusted EBITDA, but a significant net loss raises questions.

With a strong cash position, ArriVent pushes its lead lung cancer drug toward a mid-2026 data readout while building a new pipeline in ADCs.

Luminys Systems Corp. unveils its Vertical Experience Center, shifting from generic products to tailored AI security solutions for retail and education.

AFM Capital's majority stake in Incodema3D signals a major bet on advanced manufacturing for the defense, aerospace, and space industries.

A new partnership integrates conversational AI with deep EHR analysis, promising to save doctors time, improve diagnoses, and boost hospital revenue.

The Southern chicken chain lands on campus as part of a massive 20-unit Las Vegas rollout, signaling a bold new strategy for the competitive market.